Skip to content

Effect of nasal negative pressure pulsation device on airway clearance in patients with acute bronchiectasis: a non inferiority clinical study

Effect of nasal negative pressure pulsation device on airway clearance in patients with acute bronchiectasis: a non inferiority clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105694
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbation of bronchiectasis

Interventions

Intervention group:Nasal negative pressure pulsation therapy and routine airway clearance therapy were randomized

Sponsors

Department of rehabilitation medicine, China Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75; 2. Acute exacerbation of bronchiectasis was diagnosed. The acute exacerbation of bronchiectasis needs to meet the following three or more key symptoms for at least 48 hours: A. increased cough; b. Increased sputum volume and / or consistency; c. Purulent sputum; d. Dyspnea and / or decreased exercise tolerance; e. Fatigue and / or discomfort; f. Hemoptysis, and clinicians determine that it is necessary to change the treatment of bronchiectasis; 3. Agreed to participate in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: the exclusion criteria of the patients participating in this project are as follows (before the test, the subjects who belong to any of the following items shall not be enrolled): 1.accompanied by serious cardiovascular disease (such as heart failure, serious arrhythmia, etc.); 2. there is a history of massive hemoptysis (single hemoptysis > 100ml, or 24h hemoptysis > 300ml, or hemoptysis > 3 times in a week, each time > 100ml) in the past month. 3.Severe tympanic membrane lesions; 4.Psychological disease, affecting patients who understand the research content.

Design outcomes

Primary

MeasureTime frame
Sputum output in 30min (wet weight);

Secondary

MeasureTime frame
Fingertip pulse oximetry;Bedside pulmonary ventilation function;Small airway function;(visual analogue scales, VAS);

Countries

China

Contacts

Public ContactWang Siyuan

Department of rehabilitation medicine, China Japan Friendship Hospital

wsyzmx@sina.com+86 186 1033 5283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026